Insmed (INSM) Prepaid Assets (2010 - 2026)
Insmed's (INSM) quarterly Prepaid Assets came in at $78.2 million in Q1 2026, up 42.74% year-on-year from $54.8 million in Q1 2025, and down 14.29% quarter-over-quarter from $91.2 million in Q4 2025.
Insmed (INSM) Prepaid Assets (2010 - 2026) Analysis & Trends
Insmed's Prepaid Assets history runs 17 years deep, the most recent figure standing at $78.2 million for Q1 2026.
- On a quarterly basis, Prepaid Assets rose 42.74% year-over-year to $78.2 million in Q1 2026; TTM through Mar 2026 was $78.2 million, a 42.74% increase from a year earlier, with the FY2025 full-year figure at $91.2 million, up 144.96% from the prior year.
- Prepaid Assets declined to $78.2 million in Q1 2026 per INSM's latest filing, from $91.2 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $91.2 million in Q4 2025 and bottomed at $23.4 million in Q2 2022.
- The 5-year median for Prepaid Assets is $37.2 million (2024), against an average of $42.7 million.
- Across the five-year window, Prepaid Assets slipped 24.81% in 2022 and soared 144.96% in 2025, its largest moves.
- Year by year, Prepaid Assets stood at $25.5 million in 2022, then decreased by 5.06% to $24.2 million in 2023, then jumped by 54.04% to $37.2 million in 2024, then surged by 144.96% to $91.2 million in 2025, then declined by 14.29% to $78.2 million in 2026.
- Per Business Quant, the three latest INSM Prepaid Assets figures stand at $78.2 million (Q1 2026), $91.2 million (Q4 2025), and $65.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Insmed | 23.26 Bn | 22.03 Bn | 258.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78.20 Mn |
| Dec 31, 2025 | 91.24 Mn |
| Sep 30, 2025 | 65.60 Mn |
| Jun 30, 2025 | 62.18 Mn |
| Mar 31, 2025 | 54.78 Mn |
| Dec 31, 2024 | 37.25 Mn |
| Sep 30, 2024 | 41.15 Mn |
| Jun 30, 2024 | 41.02 Mn |
| Mar 31, 2024 | 42.87 Mn |
| Dec 31, 2023 | 24.18 Mn |
| Sep 30, 2023 | 27.12 Mn |
| Jun 30, 2023 | 26.36 Mn |
| Mar 31, 2023 | 28.54 Mn |
| Dec 31, 2022 | 25.47 Mn |
| Sep 30, 2022 | 25.19 Mn |
| Jun 30, 2022 | 23.36 Mn |
| Mar 31, 2022 | 31.15 Mn |
| Dec 31, 2021 | 28.90 Mn |
| Sep 30, 2021 | 25.66 Mn |
| Jun 30, 2021 | 31.07 Mn |